Shandong Wohua Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 490.09 million compared to CNY 503.42 million a year ago. Revenue was CNY 492.31 million compared to CNY 503.6 million a year ago.

Net income was CNY 37.2 million compared to CNY 56.08 million a year ago. Basic earnings per share from continuing operations was CNY 0.06 compared to CNY 0.1 a year ago. Diluted earnings per share from continuing operations was CNY 0.06 compared to CNY 0.1 a year ago.